In an unprecedented move, U.S. Senators express deep concerns over the FDA's cancellation of a critical VRBPAC meeting, risking vaccine availability during the worst flu season in 15 years. The senators demand accountability and clarity from nominee Dr. Marty Makary.
The recent cancellation of a key FDA meeting on flu vaccine strains has raised alarms among health experts, who fear it could impact vaccine quality and availability. With flu season approaching, is the U.S. prepared to protect its citizens?
